Dr. Padaliya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 W Thomas Rd
Ste 850
Phoenix, AZ 85013Phone+1 602-406-1150Fax+1 602-406-1159
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Interventional Cardiology, 2013 - 2015
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Cardiovascular Disease, 2010 - 2013
- University of MichiganResidency, Internal Medicine, 2006 - 2009
- Vanderbilt University School of MedicineClass of 2006
- Duke UniversityBS, Biology and Psychology, 1998 - 2002
Certifications & Licensure
- AZ State Medical License 2015 - 2026
- OH State Medical License 2010 - 2015
- MI State Medical License 2006 - 2013
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Chief Fellow 2012-2013
- First Year Fellow of the Year 2010-2011
Clinical Trials
- SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study Start of enrollment: 2015 Jun 01
- OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation Start of enrollment: 2015 May 01
- ILUMIEN IV: OPTIMAL PCI Start of enrollment: 2018 May 17
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsImproving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.Matheen A Khuddus, Amir Darki, Bimal B Padaliya, Nick E J West, Richard J Rapoza
Catheterization and Cardiovascular Interventions. 2022-11-01 - 279 citationsEfficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Kazuomi Kario, David E. Kandzari, Felix Mahfoud, Michael A. Weber
Lancet. 2020-05-02 - 4 citationsEarly U.S. Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold: Optimal Deployment Technique Using High Resolution Coronary Artery...David G. Rizik, Bimal Padaliya
Journal of Interventional Cardiology. 2016-10-01
Professional Memberships
- Member
Other Languages
- Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: